Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Seagen Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Kansas Medical Center
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Southern California
University of California, San Diego
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Baylor College of Medicine
Thomas Jefferson University
Incyte Corporation
UNC Lineberger Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
Merck Sharp & Dohme LLC
Agenus Inc.
Genexine, Inc.
University of Minnesota
Duke University
GOG Foundation
BeiGene
Stanford University
National Institutes of Health Clinical Center (CC)
University of Virginia
UNC Lineberger Comprehensive Cancer Center
University of Rochester
Canadian Cancer Trials Group
Imperial College London
University of California, San Diego
University of Virginia
Massachusetts General Hospital
University of Maryland, College Park
Baylor College of Medicine
Merck Sharp & Dohme LLC
Duke University
University of Miami
University of Washington
Advaxis, Inc.
Cancer Research and Biostatistics Clinical Trials Consortium
AIDS Malignancy Consortium
GlaxoSmithKline
University of Maryland, College Park
EMD Serono
National Cancer Institute (NCI)